UNIVERSITY OF UTAH
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1850-02-28
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.utah.edu
The Effectiveness of Oral Dexamethasone for Acute Bronchiolitis
- First Posted Date
- 2005-07-12
- Last Posted Date
- 2008-03-14
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 598
- Registration Number
- NCT00119002
- Locations
- 🇺🇸
Primary Children's Medical Center, Salt Lake City, Utah, United States
Angiotensin Converting Enzyme Inhibition in Children With Mitral Regurgitation
Phase 3
Terminated
- Conditions
- Heart Defects, CongenitalHeart Septal Defects, VentricularHeart Failure, Congestive
- Interventions
- Other: PlaceboDrug: Enalapril
- First Posted Date
- 2005-06-10
- Last Posted Date
- 2014-03-13
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 5
- Registration Number
- NCT00113698
- Locations
- 🇺🇸
Children's Hospital Boston, Boston, Massachusetts, United States
🇺🇸Duke University Medical Center, Durham, North Carolina, United States
🇺🇸Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Mind Engagement With Music for Nondrug Pain Relief
Phase 1
Completed
- Conditions
- Pain
- First Posted Date
- 2005-02-16
- Last Posted Date
- 2009-12-09
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 120
- Registration Number
- NCT00103870
- Locations
- 🇺🇸
University of Utah Pain Research Center, Salt Lake City, Utah, United States
Nondrug Treatment Programs for Adults With Fibromyalgia
Phase 2
Completed
- Conditions
- Fibromyalgia
- Interventions
- Behavioral: Behavioral coping skills training plus physical therapyBehavioral: Stress management education plus physical therapy
- First Posted Date
- 2004-08-05
- Last Posted Date
- 2011-08-12
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 300
- Registration Number
- NCT00088777
- Locations
- 🇺🇸
University of Utah, Pain Research and Management Center, Salt Lake City, Utah, United States
Angiotensinogen Gene and Human Hypertension
Completed
- Conditions
- Cardiovascular DiseasesHeart DiseasesHypertension
- First Posted Date
- 2003-07-01
- Last Posted Date
- 2013-07-24
- Lead Sponsor
- University of Utah
- Registration Number
- NCT00063492
Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis
Phase 2
Withdrawn
- Conditions
- Colorectal CancerSmall Intestine Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-07-24
- Lead Sponsor
- University of Utah
- Registration Number
- NCT00026468
Chronic Obstructive Pulmonary Disease Gene Localization
Completed
- Conditions
- Chronic Obstructive Pulmonary DiseaseLung Diseases
- First Posted Date
- 2002-05-21
- Last Posted Date
- 2016-01-21
- Lead Sponsor
- University of Utah
- Registration Number
- NCT00037739
Phase II Study of Growth Hormone in Children With Cystic Fibrosis
Phase 2
Completed
- Conditions
- Cystic Fibrosis
- First Posted Date
- 2001-05-07
- Last Posted Date
- 2008-09-09
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 40
- Registration Number
- NCT00016445
- Locations
- 🇺🇸
T.L. Carey, M.D. and Associates, Tulsa, Oklahoma, United States
🇺🇸Washington University, Saint Louis, Missouri, United States
🇺🇸Children's Medical Center - Dayton, Dayton, Ohio, United States
Study of Hepatic Glucose Production and De Novo Lipogenesis in Patients With Cystic Fibrosis
Completed
- Conditions
- Cystic Fibrosis
- First Posted Date
- 2001-04-11
- Last Posted Date
- 2009-03-12
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 39
- Registration Number
- NCT00014781
- Locations
- 🇺🇸
Southwest Medical Center at Dallas, Dallas, Texas, United States
Angiotensinogen Variants and Adverse Pregnancy Outcomes
Completed
- Conditions
- Cardiovascular DiseasesHeart DiseasesPre-Eclampsia
- First Posted Date
- 2000-05-26
- Last Posted Date
- 2016-01-21
- Lead Sponsor
- University of Utah
- Registration Number
- NCT00005400
© Copyright 2025. All Rights Reserved by MedPath